Fortuitous discovery of non-fluorocholine-fixing papillary carcinoma of vesicular variant of the thyroid
- 8 Downloads
Characterization of thyroid nodules is crucial to propose surgical intervention for histological verification. Cervical ultrasound potentially combined with fine needle aspiration is recommended, and fluorocholine positron emission tomography (FCH-PET), commonly used in prostatic cancers, has been evaluated in the diagnosis of thyroid cancers in recent publications.
We present two cases of patients with multinodular thyroid and primary hyperparathyroidism. The preoperative assessment consisted of an ultrasound, a MIBI scintigraphy and an FCH-PET in favor of a parathyroid adenoma.
The imaging examinations pointed to a diagnosis of a parathyroid adenoma. In both cases, papillary thyroid carcinoma, missed by FCH-PET, was discovered incidentally at a distance from the parathyroid adenoma during the surgical procedure.
These are the first descriptions of thyroid papillary carcinoma without preoperative FCH-PET identification. These clinical cases are contrary to recent publications showing a benefit of this examination in the diagnosis of thyroid cancers.
Keywords18F-Choline PET-CT Differentiated thyroid cancer PET-CT Papillary thyroid carcinoma Thyroid incidentaloma
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 3.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020 CrossRefGoogle Scholar
- 4.Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, Lefèvre M et al (2015) A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-SestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine 94(41):e1701. https://doi.org/10.1097/MD.0000000000001701 CrossRefGoogle Scholar
- 6.Kumar RG, Kalathoorakathu RR et al (2017) Comparative effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med 42(12):e491–e497. https://doi.org/10.1097/RLU.0000000000001845 CrossRefGoogle Scholar
- 7.Hodolic M, Huchet V, Balogova S, Michaud L, Kerrou K, Nataf V, Cimitan M, Fettich J, Talbot J-N (2014) Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol Oncol 48(3):228–234. https://doi.org/10.2478/raon-2013-0075 CrossRefGoogle Scholar
- 8.Thanseer NTK, Bhadada SK, Sood A, Parihar AS, Dahiya D, Singh P, Basher RK, Das A, Mittal BR (2018) Dual pathologies of parathyroid adenoma and papillary thyroid cancer on fluorocholine and fluorodeoxyglucose PET/CT. Nucl Med Mol Imaging 52(2):154–158. https://doi.org/10.1007/s13139-017-0488-3 CrossRefGoogle Scholar
- 11.Paone G, Treglia G, Bongiovanni M, Ruberto T, Ceriani L, Giovanella L (2013) Incidental detection of Hürthle cell adenoma by 18F-Choline PET/CT scan in a patient with prostate cancer. Revista Espanola De Medicina Nuclear E Imagen Molecular 32(5):340–341. https://doi.org/10.1016/j.remn.2013.04.009 CrossRefGoogle Scholar